⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Myasthenia gravis✘Lymphangiosarcoma
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 100%(3)100%(5)
General blood test 91%(9)100%(10)
Histological studies 38%(0)64%(0)
ECG 55%(0)43%(0)
Coagulogram 7%(2)68%(4)
Creatinine clearance —52%(0)
Measurements at the reception 30%(0)22%(0)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 77%—
Register, to see more distinctive signs of diseases and studies —42%
myasthenia 55% —
hyperchromia — 36%
stubborn stubborn 52% —
mastectomy — 32%
twang 52% —
metastases — 32%
difficult to swallow 44% —
leukocyturia — 30%
nose good 41% —
lymphosarcoma — 29%
crises in myasthenia gravis 39% —
cancer — 28%
progressive bulbar paralysis 38% —
lymphostasis — 27%
loss of sense of smell 37% —
ewing 's sarcoma — 27%
botulism 37% —
solid tumors — 27%
muscle fatigue 35% —
proteinuria — 27%
muscle atrophy 34% —
effects of radiation — 26%
facial muscle weakness 31% —
soft tissue sarcoma — 25%
tics 31% —
oncology — 25%
febrility 30% —
breast tumor — 25%
back pain 30% —
osteosarcoma — 24%
weakness after illness 30% —
bone cancer — 24%
complaints increase in the evening 29% —
liposarcoma — 23%
thymoma 29% —
swelling — 23%
zpr fatigue from the disease 28% —
effects of chemotherapy — 23%
antibodies to acetylcholine receptor 28% —
rhabdomyosarcoma — 23%
decreased cholinesterase 27% —
swelling of the extremities — 22%
myopathy 25% —
breast cancer — 22%
inflammatory myopathy 25% —
bone metastases — 22%
weakness of the neck muscles 24% —
hemorrhagic cystitis — 21%
quickly gets tired 31% 5%
inflammation — 21%
worse in evening 23% —
oncology in the anamnesis 7% 28%
state of exacerbation 23% —
kaposi 's sarcoma — 20%
oculopharyngeal muscular dystrophy 23% —
vascular tumor — 20%
ptosis of the upper eyelids 23% —
swollen mammary glands — 20%
double vision 23% —
malignant lymphoma — 20%
weakness in the extremities 23% —
skin problems — 20%
thing hemangioblastoma 21% —
cystitis — 19%
lambert-eaton syndrome 21% —
necrosis — 19%
chronic condition 21% —
fibrosarcoma — 19%
by erosion of the stomach 21% —
hereditary lymphedema — 19%
improvement of well-being in the evening 21% —
lymphoma — 19%
pseudobulbar syndrome 20% —
lymph node damage — 19%
amyotrophic lateral sclerosis 20% —
cancer in the anamnesis 8% 27%
thymomegaly 19% —
skin cancer — 18%
choking 19% —
basal — 18%
head is in a fog 19% —
carcinoid — 18%
paresis 19% —
epithelioma — 18%
ophthalmoplegia 19% —
radiation therapy 12% 29%
progressive paralysis 19% —
lung sarcoma — 17%
hypoxia 19% —
breast sarcoma — 17%
chokes while eating 19% —
fibroma — 16%
subacute condition 18% —
rash pustules — 16%
endocrine ophthalmopathy 18% —
suspicion — 16%
oppenheim syndrome 17% —
radiation damage 13% 29%
fasciculations 17% —
consequences of surgery 9% 25%
chews for a long 17% —
paranoia — 16%
bronchial adenoma 17% —
neurofibroma — 15%
leukoencephalitis 17% —
malignant hyperthermia — 15%
slow onset of the disease 17% —
soft tissue sarcoma in children — 15%
paralytic syndrome 17% —
abdominal surgery — 15%
cerebral circulation disorder 17% —
filariasis — 14%
neurological disorders 24% 5%
skin spots — 14%
voice is deaf 17% —
exanthema — 14%
ganglioneuritis 17% —
red papules — 14%
congenital myopathies 17% —
aggressive — 14%
better evening 16% —
hyperthermia — 14%
acute condition 16% —
protein-energy deficiency — 14%
benign ovarian tumors 16% —
radiation cystitis — 14%
crystalluria 16% —
the consequences of abdominal surgery — 14%
benign lung tumors 16% —
tumour in the abdomen — 13%
brain stem tumors 16% —
protein c deficiency — 13%
impaired nervous system function 15% —
pink spots on the skin — 13%
feeling of paralysis 15% —
metastases to the lungs — 13%
duck gait 15% —
hemorrhages on the skin — 13%
tetany 15% —
head tumor — 13%
damage to the nervous system 27% 11%
exhaustion — 13%
speech slurred 14% —
common rashes — 13%
caution 14% —
recklinghausen 's neurofibromatosis — 12%
dermatomyositis 14% —
red rash — 12%
enlarged lymph nodes of the neck 14% —
worse lying down — 12%
constipation children 14% —
pink spots — 12%
altered voice 14% —
up vascular mesh — 12%
periodic illness 31% 15%
consequences of abdominal trauma — 12%
attacks of weakness 13% —
angioplasty — 12%
the Mantoux reaction 13% —
surgical infections — 12%
glioma 13% —
angiosarcoma — 12%
myotonia 13% —
no appetite — 11%
decrease in gamma globulins 13% —
oncology relatives 8% 19%
weak lungs 13% —
muscle pain — 11%
aspiration pneumonia 13% —
leukocytosis — 11%
benign epithelial tumors 13% —
worse at 7 am — 11%
antibodies to gangliosides 13% —
diseases of the gastrointestinal tract — 11%
fog in the head 13% —
limbs pain — 11%
impaired prostate function 13% —
uterine cancer — 11%
mediastinal tumors 13% —
vascular asterisks — 11%
hoarseness voice 12% —
rashes on the chest — 11%
worse from exercise 12% —
self-injurious behavior — 11%
meningoencephalitis 12% —
tumors of peripheral nerves — 11%
sudden loss of strength 12% —
anemia — 11%
periods of exacerbation 12% —
swelling of the wound — 11%
strabismus 12% —
sensations in the extremities — 11%
can not think 12% —
takes methotrexate — 11%
ovarian tumors 12% —
aching — 11%
muscular dystrophy 12% —
melanoma — 11%
in the morning listlessness 12% —
the rashes are pink — 10%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.